Association of the -1082G/A polymorphism in the interleukin-10 gene with systemic lupus erythematosus: A meta-analysis

Gene

Volumn 519, Issue 2, 2013, Pages 209-216

  Wang, Bin ^a   Zhu, Ji Min ^a,b   Fan, Yin Guang ^a   Xu, Wang Dong ^a   Cen, Han ^a   Pan, Hai Feng ^a   Ye, Dong Qing ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Interleukin 10; Meta analysis; Polymorphism; Systemic lupus erythematosus

Indexed keywords

INTERLEUKIN 10;

ALLELE; ASIAN; CAUCASIAN; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HETEROZYGOTE; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CONFIDENCE INTERVALS; DATABASES, GENETIC; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84875627992     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.01.026     Document Type: Review

References (44)

1. Attia J., Thakkinstian A., D'Este C. Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J. Clin. Epidemiol. 2003, 56:297-303.
2. Blair P.A., et al. CD19(t) CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010, 32:129-140.
3. Chong W.P., Ip W.K., Wong W.H., Lau C.S., Chan T.M., Lau Y.L. Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun. 2004, 5(6):484-492.
4. Cochran W.G. The combination of estimates from different experiments. Biometrics 1954, 10:101-129.
5. Crawley E., Woo P., Isenberg D.A. Single nucleotide polymorphic haplotypes of the interleukin-10 5' flanking region are not associated with renal disease or serology in Caucasian patients with systemic lupus erythematosus. Arthritis Rheum. 1999, 42(9):2017-2018.
6. D'Alfonso S., et al. Association tests with systemic lupus erythematosus (SLE) of IL10 markers indicate a direct involvement of a CA repeat in the 5' regulatory region. Genes Immun. 2002, 3(8):454-463.
7. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control. Clin. Trials 1986, 7:177-178.
8. Dijstelbloem H.M., et al. The R-H polymorphism of FCgamma receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter. Arthritis Rheum. 2002, 46(4):1125-1126.
9. Fei G.Z., Svenungsson E., Frostegård J., Padyukov L. The A-1087IL-10 allele is associated with cardiovascular disease in SLE. Atherosclerosis 2004, 177(2):409-414.
10. Guarnizo-Zuccardi P., et al. Cytokine gene polymorphisms in Colombian patients with systemic lupus erythematosus. Tissue Antigens 2007, 70(5):376-382.
11. Guzowski D., et al. Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography. J. Biomol. Tech. 2005, 16:154-166.
12. Harley J.B., Kelly J.A., Kaufman K.M. Unraveling the genetics of systemic lupus erythematosus. Springer Semin. Immunopathol. 2006, 28:119-130.
13. Hee C.S., Gun S.C., Naidu R., Somnath S.D., Radhakishnan A.K. The relationship between single nucleotide polymorphisms of the interleukin-10 gene promoter in systemic lupus erythematosus patients in Malaysia: a pilot study. Int. J. Rheum. Dis. 2008, 11:148-154.
14. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a metaanalysis. Stat. Med. 2002, 21:1539-1558.
15. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. Br. Med. J. 2003, 327:557-560.
16. Hirankarn N., et al. The synergistic effect of FC gamma receptor IIa and interleukin-10 genes on the risk to develop systemic lupus erythematosus in Thai population. Tissue Antigens 2006, 68(5):399-406.
17. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725.
18. Hrycek A., Siekiera U., Cieślik P., Szkróbka W. HLA-DRB1 and -DQB1 alleles and gene polymorphisms of selected cytokines in systemic lupus erythematosus. Rheumatol. Int. 2005, 26(1):1-6.
19. Ishida H., Muchamuel T., Sakaguchi S., Andrade S., Menon S., Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 1994, 179(1):305-310.
20. Kelly J.A., Moser K.L., Harley J.B. The genetics of systemic lupus erythematosus: putting the pieces together. Genes Immun. 2002, 3(Suppl. 1):S71-S85.
21. Khoa P.D., Sugiyama T., Yokochi T. Polymorphism of interleukin-10 promoter and tumor necrosis factor receptor II in Vietnamese patients with systemic lupus erythematosus. Clin. Rheumatol. 2005, 24(1):11-13.
22. Lazarus M., et al. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J. Rheumatol. 1997, 24(12):2314-2317.
23. Lee Y.H., Choi S.J., Ji J.D., Song G.G. Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: a meta-analysis. Inflamm. Res. 2012, 61(7):657-663.
24. Lin Y.J., et al. IL-10 and TNF-alpha promoter polymorphisms in susceptibility to systemic lupus erythematosus in Taiwan. Clin. Exp. Rheumatol. 2010, 28:318-324.
25. Llorente L., et al. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum. 1997, 40(8):1429-1435.
26. López P., Gómez J., Mozo L., Gutiérrez C., Suárez A. Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs. Arthritis Res. Ther. 2006, 8(2):R42.
27. López P., Gutiérrez C., Suárez A. IL-10 and TNFα genotypes in SLE. J. Biomed. Biotechnol. 2010, 10:1-10.
28. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl Cancer Inst. 1959, 22:719-728.
29. Mok C.C., Lanchbury J.S., Chan D.W., Lau C.S. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum. 1998, 41(6):1090-1095.
30. Moore K.W., de Waal M.R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
31. Nath S.K., Kilpatrick J., Harley J.B. Genetics of human systemic lupus erythematosus: the emerging picture. Curr. Opin. Immunol. 2004, 16:794-800.
32. Nath S.K., Harley J.B., Lee Y.H. Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum. Genet. 2005, 118:225-234.
33. Pacheco A.G., Cardoso C.C., Moraes M.O. IFNG +874T/A, IL10 -1082G/A and TNF -308G/A polymorphisms in association with tuberculosis susceptibility: a meta-analysis study. Hum. Genet. 2008, 123:477-484.
34. Rood M.J., et al. Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes. Ann. Rheum. Dis. 1999, 58(2):85-89.
35. Rosado S., et al. Interleukin-10 promoter polymorphisms in patients with systemic lupus erythematosus from the Canary Islands. Int. J. Immunogenet. 2008, 35(3):235-242.
36. Stroup D.F., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
37. Suárez A., López P., Mozo L., Gutiérrez C. Differential effect of IL10 and TNF{alpha} genotypes on determining susceptibility to discoid and systemic lupus erythematosus. Ann. Rheum. Dis. 2005, 64(11):1605-1610.
38. Tan E.M., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25:1271-1277.
39. Teo K.K., Yusuf S., Collins R., Held P.H., Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials. BMJ 1991, 303:1499-1503.
40. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet. 1997, 24:1-8.
41. van der Linden M.W., Westendorp R.G., Sturk A., Bergman W., Huizinga T.W. High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus. J. Investig. Med. 2000, 48(5):327-334.
42. Yin Z., et al. IL-10 regulates murine lupus. J. Immunol. 2002, 169:2148-2155.
43. Yu H.H., et al. Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients. Lupus 2010, 19(10):1219-1228.
44. Zhang J., et al. The -1082A/G polymorphism in the Interleukin-10 gene and the risk of rheumatoid arthritis: a meta-analysis. Cytokine 2011, 56(2):351-355.